influenza
one
common
vaccineprevent
viral
diseas
highest
morbid
report
children
elderli
patient
influenza
infect
childhood
usual
present
mild
respiratori
upper
airway
diseas
sever
complic
fatal
also
occur
especi
children
less
year
age
children
underli
chronic
condit
howev
influenzaassoci
fatal
occur
previous
healthi
children
influenza
pandem
comparison
clinic
characterist
patient
infect
differ
influenza
type
vs
b
patient
infect
differ
influenza
subtyp
show
small
differ
control
age
pandem
howev
studi
observ
increas
morbid
mortal
among
children
compar
previou
season
influenza
studi
describ
clinic
featur
similar
even
milder
acut
respiratori
distress
syndrom
ard
fatal
viral
pneumonia
observ
frequent
pandem
postpandem
surveil
recommend
circul
expect
continu
sever
year
gradual
assum
season
influenza
pattern
germani
influenza
sentinel
surveil
outpati
age
confirm
first
postpandem
season
domin
influenza
cocircul
influenza
b
wherea
rare
second
season
rare
wherea
diagnos
case
cocircul
influenza
b
third
season
three
typessubtyp
cocircul
similar
proport
b
inform
incid
clinic
characterist
sever
paediatr
influenza
result
intens
care
treatment
andor
fatal
outcom
still
limit
germani
postpandem
data
thu
far
avail
season
base
case
record
nationwid
paediatr
intens
care
unit
picu
report
system
prepandem
pandem
postpandem
annual
incid
sever
influenza
case
per
children
year
age
estim
respect
data
far
avail
indic
shift
toward
younger
children
case
pandem
first
postpandem
season
studi
remain
unclear
whether
higher
pandem
postpandem
incid
children
caus
higher
influenza
activ
heighten
physician
awar
frequent
sensit
influenza
test
sever
cours
diseas
furthermor
previou
studi
may
affect
underreport
influenza
case
report
discret
picu
physician
without
systemat
screen
influenza
patient
sever
acut
respiratori
infect
studi
present
use
activ
screen
estim
incid
laboratoryconfirm
influenzaassoci
picu
admiss
one
germani
largest
feder
state
first
three
postpandem
season
furthermor
describ
clinic
characterist
influenza
picu
patient
compar
patient
sever
diseas
postpandem
season
prospect
activ
surveil
conduct
picu
paediatr
hospit
bavaria
germani
decemb
st
roughli
children
year
age
regist
bavaria
repres
german
popul
age
group
annual
studi
popul
defin
subgroup
children
bavaria
least
month
year
age
paediatr
hospit
bavaria
equip
paediatr
intens
care
treatment
children
older
month
age
invit
particip
picu
report
total
intens
care
bed
median
iqr
includ
bed
median
iqr
equip
ventil
facil
patient
fulfil
follow
inclus
criteria
enrol
admiss
particip
picu
suspect
acut
respiratori
infect
ari
upper
lower
respiratori
tract
arirel
symptom
exampl
coryza
cough
sore
throat
ii
age
picu
admiss
due
ari
least
month
year
age
iii
parent
written
inform
consent
enrol
children
pcrconfirm
influenza
class
influenzaassoci
ari
picu
physician
document
demograph
characterist
underli
chronic
medic
condit
influenza
vaccin
statu
diagnost
find
ariassoci
diagnos
complic
treatment
durat
hospit
picu
stay
outcom
structur
questionnair
respiratori
sampl
usual
flock
nasopharyng
pharyng
swab
collect
day
picu
admiss
pcrconfirm
influenza
microbiolog
test
bacteria
fungi
discret
picu
physician
pathogen
detect
usual
steril
site
tracheal
aspir
classifi
bacteri
fungal
coinfect
pcr
confirm
influenza
perform
either
local
laboratori
particip
picu
use
influenzaspecif
pcr
major
case
central
laboratori
institut
virolog
immunobiolog
univers
use
multiplex
pcr
respiratori
virus
latter
respiratori
sampl
place
viral
transport
medium
mast
diagnostica
gmbh
reinfeld
germani
central
laboratori
test
use
commerci
multiplex
pcr
respiratori
pathogen
fast
track
diagnost
luxembourg
screen
respiratori
virus
sensit
specif
compar
singleplex
pcr
assay
includ
virus
clinic
sampl
pathogen
detect
test
kit
includ
influenza
b
virus
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
coronaviru
cov
human
metapneumoviru
hmpv
human
bocaviru
hbov
adenoviru
adv
rhinoviru
rhv
enteroviru
ev
parechoviru
pv
addit
mykoplasma
pneumonia
sampl
posit
influenza
b
viru
rna
multiplex
pcr
analys
determin
subtyp
lineag
respect
primer
probe
specif
influenza
includ
ftd
respiratori
pathogen
kit
sampl
posit
influenza
viru
rna
neg
influenza
viru
rna
test
pcr
specif
influenza
viru
data
enter
microsoft
access
databas
transfer
ibm
spss
statist
analysi
data
analys
descript
percentag
median
interquartil
rang
iqr
comparison
group
assess
signific
p
twosid
use
pearson
chi
test
fisher
exact
test
categor
data
mannwhitney
utest
continu
data
minimum
incid
influenzaassoci
picu
admiss
per
children
year
age
calcul
season
base
observ
number
influenza
picu
patient
residenti
address
bavaria
correct
nonparticip
picu
estim
total
number
picu
influenza
case
treat
elig
picu
bavaria
per
season
deriv
take
account
annual
percentag
particip
picu
annual
studi
popul
use
denomin
similar
questionnair
case
definit
use
previou
studi
influenzarel
picu
admiss
key
variabl
extract
public
comparison
purpos
data
streng
et
al
present
studi
pool
statist
comparison
preand
postpandem
season
studi
approv
ethic
committe
medic
faculti
univers
germani
base
observ
case
minimum
incid
pcrconfirm
influenzaassoci
picu
admiss
per
children
year
age
bavaria
calcul
season
respect
take
account
observ
case
base
data
elig
picu
total
number
influenzaassoci
picu
admiss
bavaria
estim
correct
incid
calcul
per
children
year
subtypespecif
correct
incid
tabl
onset
ari
symptom
children
admit
hospit
median
interv
day
transfer
picu
day
hospit
admiss
follow
day
tabl
two
longterm
hospit
children
requir
picu
treatment
due
ari
diagnos
suspect
nosocomi
influenza
infect
median
length
picu
stay
day
median
length
total
hospit
stay
day
tabl
underli
chronic
medic
condit
report
total
influenza
picu
patient
tabl
chronic
neurolog
diseas
frequent
follow
chronic
lung
diseas
preterm
birth
cardiac
malform
obes
genet
disord
immunocompromis
condit
influenza
picu
patient
underli
chronic
condit
four
young
month
age
immun
influenza
two
patient
data
influenza
vaccin
statu
unavail
twentynin
patient
risk
group
vaccin
influenza
although
would
elig
one
immunocompromis
child
vaccin
octob
diagnos
januari
one
specif
influenzaassoci
diagnosescompl
report
children
tabl
frequent
diagnosi
influenzaassoci
pneumonia
follow
bronchiti
bronchiol
secondari
bacteri
pneumonia
ard
report
sepsi
six
children
complic
rare
thirtynin
patient
underw
chest
radiograph
addit
influenza
laboratoryconfirm
coinfect
report
children
major
picu
patient
treat
intraven
antibiot
antipyret
five
children
infect
die
age
year
four
male
patient
tabl
four
children
suffer
sever
neurolog
condit
two
children
previou
peripart
asphyxia
spastic
tetraparesi
one
child
cerebr
paresi
tetraspast
one
child
congenit
cerebr
disord
chronic
pulmonari
condit
two
four
children
also
born
preterm
influenzaassoci
pneumonia
diagnos
four
children
three
addit
secondari
bacteri
pneumonia
one
child
also
develop
sepsi
fifth
child
obes
report
risk
factor
sepsi
suspect
enceph
complic
bacteri
copathogen
detect
three
five
children
suspect
one
child
two
viral
two
fungal
coinfect
also
report
five
children
receiv
intratrach
ventil
antibiot
catecholamin
two
addit
treat
antivir
medic
death
occur
day
picu
admiss
ard
report
caus
death
three
children
sequela
report
five
patient
state
surgeri
due
pleural
effusionempyema
two
children
increas
oxygen
requir
two
children
previous
alreadi
receiv
oxygen
therapi
home
damag
lung
highpressur
ventil
one
child
tabl
figur
show
differ
age
distribut
season
high
proport
children
year
age
oppos
low
proport
age
group
season
onset
symptom
children
admit
picu
significantli
shorter
period
median
day
iqr
season
compar
day
iqr
season
tabl
season
significantli
fewer
children
diagnos
bronchitisbronchiol
tabl
tend
requir
cpap
treatment
less
frequent
season
vs
p
tabl
prepandem
period
median
durat
picu
stay
longer
day
children
often
diagnos
encephalitisencephalopathi
coinfect
later
period
tabl
proport
children
influenzaassoci
pneumonia
highest
pandem
wherea
secondari
bacteri
pneumonia
bronchiti
bronchiol
sepsi
report
less
frequent
pandem
preand
postpandem
season
oseltamivir
treatment
decreas
significantli
postpandem
period
tabl
first
three
postpandem
season
activ
screen
children
acut
respiratori
infect
admit
paediatr
intens
care
unit
bavaria
identifi
total
pcrconfirm
influenza
case
result
annual
incid
estim
influenzaassoci
picu
admiss
per
children
respect
figur
would
extrapol
correspond
total
number
children
influenzaassoci
picu
admiss
germani
within
postpandem
period
annual
averag
children
almost
time
high
annual
averag
six
seven
influenzaassoci
picu
admiss
detect
nationwid
picu
surveil
germani
three
prepandem
year
without
activ
screen
furthermor
incid
estim
subtyp
deriv
activ
screen
studi
higher
first
third
postpandem
season
respect
previou
incid
estim
picu
patient
pandem
first
postpandem
approxim
season
germani
thu
result
indic
possibl
underreport
previou
studi
show
continu
high
level
picu
admiss
even
year
pandem
studi
proport
children
bacteriaassoci
complic
secondari
bacteri
pneumonia
sepsi
similar
proport
observ
prepandem
period
appear
higher
observ
pandem
lower
proport
observ
pandem
might
explain
time
shift
peak
influenza
case
observ
earli
novemb
germani
thu
pandem
influenza
peak
coincid
season
peak
streptococcu
pneumonia
bacteri
pathogen
frequent
associ
communityacquir
influenza
antivir
treatment
pattern
chang
consider
postpandem
period
decreas
proport
paediatr
influenza
case
receiv
oseltamivir
previous
oseltamivir
consid
advantag
administ
within
first
h
influenza
diseas
reduc
use
postpandem
period
may
therefor
partli
due
fact
median
time
onset
influenza
symptom
picu
admiss
longer
pandem
vs
day
increas
uncertainti
regard
effect
oseltamivir
treatment
paediatr
influenza
may
also
play
role
postpandem
oseltamivir
treatment
associ
coinfect
longer
picu
stay
suggest
mainli
children
sever
complic
seriou
underli
condit
receiv
medic
studi
twothird
influenza
case
fatal
postpandem
season
proport
case
among
picu
patient
thu
consider
higher
proport
subtyp
report
among
outpati
nation
influenza
surveil
observ
suggest
may
associ
often
sever
cours
influenza
requir
picu
treatment
influenza
type
subtyp
similar
observ
proport
picu
admiss
report
unit
state
comparison
picu
patient
postpandem
season
show
median
age
year
third
season
thu
significantli
lower
first
season
signific
age
shift
toward
younger
children
median
age
year
alreadi
observ
comparison
pandem
first
postpandem
season
germani
continu
shift
toward
younger
patient
third
season
like
due
increas
immun
older
paediatr
popul
previou
contact
seropreval
data
germani
alreadi
shown
evid
infect
mani
children
age
year
yearold
children
pandem
season
similar
shift
toward
younger
hospit
children
toward
younger
children
sever
paediatr
influenza
pandem
season
first
postpandem
season
also
detect
european
countri
germani
paediatr
influenza
vaccin
pandem
influenza
recommend
fund
children
monoval
vaccin
octob
juli
season
influenza
howev
paediatr
influenza
vaccin
current
recommend
specif
risk
group
underli
chronic
condit
vaccin
uptak
low
even
target
group
prepandem
vaccin
rate
children
children
chronic
underli
condit
pandem
postpandem
season
data
vaccin
rate
avail
children
vaccin
rate
low
report
adult
vaccin
rate
even
risk
group
adult
studi
influenzaassoci
picu
patient
children
underli
chronic
condit
analysi
report
influenza
data
given
age
group
season
season
n
season
n
season
n
shown
vaccin
statu
show
among
high
proport
vaccineelig
unvaccin
children
patient
chronic
condit
young
vaccin
paediatr
risk
group
otherwis
healthi
children
year
age
cover
current
german
recommend
group
could
profit
consider
univers
influenza
vaccin
children
either
directli
herd
protect
contrast
situat
germani
unit
state
univers
influenza
vaccin
children
older
month
age
establish
vaccin
coverag
reach
level
approxim
compar
influenzaassoci
paediatr
death
observ
unit
state
pandem
observ
strong
season
might
partli
explain
increas
immun
children
previou
infect
may
part
also
result
influenza
vaccin
program
england
univers
childhood
vaccin
programm
new
live
attenu
influenza
vaccin
laiv
intranas
applic
start
influenza
season
first
result
show
overal
uptak
primari
school
age
children
indic
good
accept
laiv
suggest
direct
indirect
impact
diseas
incid
includ
reduct
paediatr
influenzaassoci
hospitalis
knowledg
studi
first
europ
investig
paediatr
influenza
picu
patient
first
three
postpandem
season
pandem
strength
studi
includ
multicentr
design
cover
major
picu
bavaria
activ
screen
influenza
patient
admit
picu
pcrconfirm
influenza
case
limit
correct
incid
estim
base
assumpt
particip
nonparticip
picu
treat
similar
number
sever
paediatr
influenza
patient
although
picu
group
similar
size
nonparticip
picu
paediatrician
indic
lack
time
reason
nonparticip
may
treat
higher
number
patient
patient
higher
acuiti
limit
includ
potenti
overand
underreport
particip
picu
one
hand
due
differ
hospit
rule
children
may
admit
picu
mainli
purpos
monitor
cours
influenza
diseas
close
thu
result
overestim
sever
case
hand
parent
children
sever
influenza
may
refus
studi
particip
children
fulmin
cours
influenza
diseas
may
die
admit
picu
thu
high
incid
estim
deriv
studi
may
still
underestim
true
burden
sever
influenza
b
key
data
studi
pool
data
streng
et
al
compar
use
fisher
exact
test
mannwhitney
utest
respect
incid
estim
influenza
picu
admiss
deriv
activ
screen
picu
patient
acut
respiratori
infect
reach
similarli
high
level
first
third
postpandem
season
incid
estim
higher
previous
report
nationwid
picu
surveil
pandem
first
postpandem
season
suggest
possibl
underreport
previou
studi
without
activ
screen
comparison
first
third
postpandem
season
indic
age
shift
sever
toward
younger
children
might
explain
increas
immun
older
paediatr
popul
larg
proport
children
underli
chronic
condit
indic
need
consist
implement
current
recommend
influenza
vaccin
specif
risk
group
germani
children
could
also
profit
herd
protect
univers
influenza
vaccin
success
introduc
germani
author
contribut
design
studi
coordin
data
collect
perform
analysi
interpret
data
draft
manuscript
bw
cp
perform
multiplex
pcr
subtyp
laboratori
specimen
interpret
virolog
data
revis
manuscript
jgl
supervis
studi
support
data
interpret
revis
manuscript
clinic
data
collect
bavarian
picu
studi
group
influenza
viral
ari
oct
septemb
author
read
approv
final
manuscript
